CALIMAN, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 1.705
AS - Asia 1.522
EU - Europa 1.482
SA - Sud America 106
AF - Africa 31
OC - Oceania 22
Totale 4.868
Nazione #
US - Stati Uniti d'America 1.657
RU - Federazione Russa 530
IT - Italia 494
SG - Singapore 474
CN - Cina 467
HK - Hong Kong 180
KR - Corea 126
VN - Vietnam 102
IE - Irlanda 96
BR - Brasile 89
FR - Francia 61
PL - Polonia 60
DE - Germania 59
FI - Finlandia 54
IN - India 49
SE - Svezia 38
GB - Regno Unito 30
JO - Giordania 27
BD - Bangladesh 26
CA - Canada 25
ID - Indonesia 22
AU - Australia 21
NL - Olanda 16
JP - Giappone 11
NG - Nigeria 11
CH - Svizzera 10
AT - Austria 8
IQ - Iraq 8
MX - Messico 8
ES - Italia 7
PK - Pakistan 6
PH - Filippine 5
UA - Ucraina 5
UZ - Uzbekistan 5
AR - Argentina 4
CL - Cile 4
EC - Ecuador 4
MA - Marocco 4
BJ - Benin 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
SV - El Salvador 2
TR - Turchia 2
ZA - Sudafrica 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.868
Città #
Santa Clara 457
Singapore 363
Ashburn 338
Hefei 169
Hong Kong 161
Seoul 126
San Jose 122
Dublin 96
Milan 88
Florence 68
Warsaw 58
Beijing 50
Los Angeles 50
Rome 48
Council Bluffs 46
Chandler 40
The Dalles 37
Helsinki 34
Munich 34
Buffalo 32
Dallas 31
Ho Chi Minh City 29
Paris 29
Hanoi 25
New York 25
Jakarta 22
Lauterbourg 22
Melbourne 21
Kent 20
Boardman 19
Shanghai 18
Moscow 17
Fairfield 16
Mumbai 16
Bengaluru 12
London 12
Seattle 12
Abuja 11
Tokyo 11
Turku 11
Altamura 9
Boston 9
Naples 9
Woodbridge 9
Frankfurt am Main 8
Houston 8
Lappeenranta 8
Lawrence 8
Toronto 8
Vienna 8
Orem 7
Pune 7
São Paulo 7
Brescia 6
Chennai 6
Genoa 6
Haiphong 6
Ancona 5
Montreal 5
Palermo 5
Verona 5
Acton 4
Bern 4
Bologna 4
Brooklyn 4
Douglasville 4
Elk Grove Village 4
Figino 4
Guangzhou 4
Lahore 4
Nuremberg 4
Ottawa 4
Ovada 4
Princeton 4
Rio de Janeiro 4
San Francisco 4
Turin 4
Wilmington 4
Yubileyny 4
Zhengzhou 4
Alba 3
Amsterdam 3
Bremen 3
Buenos Aires 3
Chicago 3
Cotonou 3
Dhaka 3
Duque de Caxias 3
Lecce 3
Macerata 3
Madrid 3
Miami 3
Miano 3
Olomouc 3
Oslo 3
Phoenix 3
Piscataway 3
Poplar 3
Recanati 3
Ribeirão Preto 3
Totale 3.081
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 287
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 269
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 248
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 240
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 237
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 212
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 207
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 192
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 190
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 183
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 181
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 179
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 179
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 177
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 175
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 173
Induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (Hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report 164
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 163
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 163
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 160
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 138
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 136
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 133
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 133
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 130
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 93
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm? 90
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC 59
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma 38
Totale 4.929
Categoria #
all - tutte 15.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 2 1 0 0 2 2 5 0 2 3 10
2022/2023302 7 27 5 29 15 52 45 37 47 13 16 9
2023/2024358 10 14 27 19 24 47 23 77 11 19 35 52
2024/20251.758 63 161 93 274 392 223 53 104 95 58 102 140
2025/20262.318 296 301 307 176 226 73 287 108 146 165 78 155
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 4.929